EC
Insider
Edward Carr
CHIEF ACCOUNTING OFFICEREdward Carr (CHIEF ACCOUNTING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $3.5M of DNTH (43,182 sh across 3 lots, as filed), executed Mar 12.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.5M
shares × price, as filed
Last traded
Sep 17
Filed Sep 18
Median ADV $122.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DNTHRecent filings
DNTHSALE
Dianthus Therapeutics, Inc.
View filing →
$2.0M19,300 sh across 4 lots
Exec Sep 17
Filed Sep 18 · 4:36 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $3.5M
43,182 sh across 3 lots
Exec Mar 12
Filed Mar 13 · 5:30 PM ET